McCloskey, E. http://orcid.org/0000-0003-0177-8140
Rathi, J.
Heijmans, S.
Blagden, M.
Cortet, B.
Czerwinski, E.
Hadji, P.
Payer, J.
Palmer, K.
Stad, R.
O’Kelly, J.
Papapoulos, S.
Funding for this research was provided by:
Amgen
Article History
Received: 22 March 2020
Accepted: 21 July 2020
First Online: 23 August 2020
Compliance with ethical standards
: The study has been approved by the appropriate institutional and/or national research ethics committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Eugene McCloskey: grants/research support from ActiveSignal, Amgen, AR UK, AstraZeneca, Consilient Healthcare, GSK, Hologic, I3 Innovus, Internis, IOF, Lilly, Medtronic, Merck, MRC, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Synexus, Tethys, UCB, Unilever, and Warner Chilcott; consultant for ActiveSignal, Amgen, Consilient Healthcare, Fresenius Kabi, GSK, Synexus, and UCB; speaking fees from Agnovos, Amgen, AstraZeneca, Consilient Healthcare, GSK, Hologic, Internis, Lilly, Pfizer, Roche, Servier, and UCB. Bernard Cortet has received fees for occasional interventions as an expert or speaker from Alexion, Amgen, Expanscience, Ferring, Lilly, Medtronic, MSD, Mylan, Novartis, Roche Diagnostics, and UCB. E. Czerwinski: traveling grant from Amgen. Kerry Palmer, Robert Stad, James O’Kelly: Amgen employment and stock ownership. Socrates Papapoulos: consulting/speaking fees from Amgen, Axsome, Gador, Radius Health, UCB. Peyman Hadji: grants/research, consultancy, and lecture fees from Amgen, AstraZeneca, Dr. Kade/Besins, Exeltis, Gedeon Richter, Hexal, Hologic, Lilly, Mylan, Novartis, Pfizer, and UCB. Jeetandera Rathi, Stephane Heijmans, Mark Blagden, Juraj Payer: no disclosures.